Search clinical trials for: rituximab and lenalidomide
Total 269809 results
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
University of BolognaTerminated
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Henan Cancer HospitalRecruiting
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
Tianjin Medical University Cancer Institute and...Recruiting
-
University of ChicagoCelgene CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Qingdao Central HospitalRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingNeoplasms by Histologic Type | Lymphoma, Large B-Cell, DiffuseChina
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Ruijin HospitalThe First Affiliated Hospital of Nanchang University; Qilu Hospital of Shandong... and other collaboratorsRecruiting
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Weill Medical College of Cornell UniversityCelgeneCompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B Cell LymphomaChina
-
Swiss Group for Clinical Cancer ResearchCompleted
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Zhejiang Cancer HospitalUnknownAngioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
First Affiliated Hospital of Wenzhou Medical UniversityRecruitingDiffuse Large B Cell LymphomaChina
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
University Hospital, LilleCelgene CorporationCompletedWaldenstrom MacroglobulinemiaFrance
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States